Technology
Health
Biotechnology
ARCA biopharma
$0.399876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.39
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0214 (-5.20%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell ARCA biopharma and other stocks, options, ETFs, and crypto commission-free!
About
ARCA biopharma, Inc. Common Stock, also called ARCA biopharma, is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. Read More The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
Employees
15
Headquarters
Westminster, Colorado
Founded
1992
Market Cap
5.43M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
797.71K
High Today
$0.4099
Low Today
$0.37
Open Price
$0.4001
Volume
272.07K
52 Week High
$1.28
52 Week Low
$0.2625
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Medical
Pharmaceutical
US
North America
News
MarketBeatMar 8
Stock Price, News, & Analysis for Arca Biopharma
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. The company's lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator, which is in clinical trial for the treatment of atrial fibrillation in chronic heart failure patients with reduced left ventricular ejection fraction. It also engages in the development of a preclinical plan for AB171, a new chemical entity for the treatment of various cardi...
Price Paid on Robinhood
34% Lower
Right Now
52 Week Low
$0.2625
Average Price Paid
$0.5899
52 Week High
$1.28
Earnings
-$0.59
-$0.39
-$0.20
$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 7, After Hours